China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026)
China Pharma Holdings (CPHI) reported Change in Inventory of -$247492.0 for Q1 2026, down 58.01% on a YoY basis from -$589457.9 in Q1 2025, and down 17.54% quarter-over-quarter from -$210551.0 in Q4 2025.
China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Change in Inventory for 17 years, with the latest figure at -$247492.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory fell 58.01% year-over-year to -$247492.0; the trailing twelve-month figure through Mar 2026 stood at -$680626.0 (up 58.13% YoY), and the FY2025 full-year result was -$589761.0, up 63.3% from the prior year.
- Change in Inventory for Q1 2026 stood at -$247492.0, down from -$210551.0 in the prior quarter.
- The five-year high for Change in Inventory was $552686.0 in Q1 2023, with the low at -$582187.0 in Q3 2022.
- Historically, Change in Inventory has averaged -$183305.1 across 5 years, with a median of -$210551.0 in 2025.
- The largest YoY upside for Change in Inventory was 311.81% in 2022 against a maximum downside of 533.35% in 2022.
- China Pharma Holdings' Change in Inventory stood at -$192902.0 in 2022, then plunged by 34.09% to -$258659.0 in 2023, then tumbled by 97.56% to -$510996.0 in 2024, then surged by 58.8% to -$210551.0 in 2025, then slipped by 17.54% to -$247492.0 in 2026.
- The last three Change in Inventory figures came in at -$247492.0 (Q1 2026), -$210551.0 (Q4 2025), and -$57779.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -2.11 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 20.30 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -247,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247,492.00 |
| Mar 31, 2026 | -247,492.00 |
| Dec 31, 2025 | -210,551.00 |
| Dec 31, 2025 | -210,551.00 |
| Sep 30, 2025 | -57,779.00 |
| Sep 30, 2025 | -57,779.00 |
| Jun 30, 2025 | -164,804.00 |
| Jun 30, 2025 | -164,804.00 |
| Mar 31, 2025 | -156,627.00 |
| Mar 31, 2025 | -156,627.00 |
| Dec 31, 2024 | -510,996.00 |
| Dec 31, 2024 | -510,996.00 |
| Sep 30, 2024 | -376,771.00 |
| Sep 30, 2024 | -376,771.00 |
| Jun 30, 2024 | -581,031.00 |
| Jun 30, 2024 | -581,031.00 |
| Mar 31, 2024 | -138,090.00 |
| Mar 31, 2024 | -138,090.00 |
| Dec 31, 2023 | -258,659.00 |
| Dec 31, 2023 | -258,659.00 |